THRX - Theseus Pharmaceuticals - Stock Forecast

Coverage Performance Price Targets & Ratings Chart Insider Trading

THRX is currently covered by 4 analysts with an average price target of $13.06. This is a potential upside of $9 (221.67%) from yesterday's end of day stock price of $4.06.

Theseus Pharmaceuticals's activity chart (see below) currently has 1 price targets and 15 ratings on display. The stock rating distribution of THRX is 85.71% BUY and 14.29% HOLD.

Stock Analyst Price Targets - Review

Highest price target for THRX is $9, Lowest price target is $7, average price target is $13.06.

Most recent stock forecast was given by AMI FADIA from NEEDHAM on 14-Jul-2023. First documented stock forecast 02-Nov-2021.

Currently out of the existing stock ratings of THRX, 12 are a BUY (85.71%), 2 are a HOLD (14.29%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

23

9 months 3 days ago

0/5 (0%)

$15.26 (197.16%)

Buy

9

$4.94 (121.67%)

22

9 months 3 days ago

0/5 (0%)

$6.34 (238.35%)

Buy

7

$2.94 (72.41%)

24

9 months 3 days ago

0/2 (0%)

$4.34 (163.16%)

Buy

7

$2.95 (72.84%)

25

9 months 4 days ago

0/2 (0%)

$4.34 (163.16%)

Hold

24

10 months 25 days ago

0/1 (0%)

$16.2 (207.69%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is THRX (Theseus Pharmaceuticals) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on THRX (Theseus Pharmaceuticals) with a proven track record?

AMI FADIA

Which analyst has the current lower performing score on THRX (Theseus Pharmaceuticals) with a proven track record?

MAURY RAYCROFT

Which analyst has the most public recommendations on THRX (Theseus Pharmaceuticals)?

Ami Fadia works at NEEDHAM and has 7 price targets and 8 ratings on THRX

Which analyst is the currently most bullish on THRX (Theseus Pharmaceuticals)?

Andrew Berens with highest potential upside - $23.95

Which analyst is the currently most reserved on THRX (Theseus Pharmaceuticals)?

Ami Fadia with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?